Photoprotection by sunscreens with topical antioxidants and systemic antioxidants to reduce sun exposure

Journal of Long-Term Effects of Medical Implants

Volumn 14, Issue 4, 2004, Pages 317-340

  Edlich, Richard F ^a,i   Winters, Kathryne L ^a   Lim, Henry W ^b,c   Cox, Mary Jude ^d   Becker, Daniel G ^e   Horowitz, Jed H ^f   Nichter, Larry S ^f   Britt, L D ^g   Long, William B ^h  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b HENRY FORD HEALTH SYSTEM   (United States)

^c Skin Cancer Foundation   (Australia)

^d Eye Phys of Southern New Jersey   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f Pacific Center for Plastic Surgery   (United States)

^g EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^h LEGACY EMANUEL HOSPITAL   (United States)

ⁱ NONE   (United States)

Author keywords

Minimal erythema dose; Ozone layer; Sun protection factor; Sunscreen; Sunscreen photostability; Sunscreen phototoxicity; Sunscreen preservatives; Ultraviolet A I; Ultraviolet A II; Ultraviolet B; Ultraviolet C; Ultraviolet index; Vehicles

Indexed keywords

DRUG PRODUCTS; EPIDEMIOLOGY; PHOTOCHEMICAL REACTIONS; RISK ASSESSMENT; SKIN; SUN; TUMORS;

PHOTOPROTECTION; SKIN CANCER;

ANTIOXIDANTS;

4 METHOXYCINNAMIC ACID 2 ETHYLHEXYL ESTER; AMINOBENZOIC ACID; ANTHRANILIC ACID METHYL ESTER; ANTIOXIDANT; AVOBENZONE; CINOXATE; DIOXYBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE; PADIMATE; PHENYLBENZIMIDAZOLESULFONIC ACID; SULISOBENZONE; SUNSCREEN; TITANIUM DIOXIDE; TRIETHANOLAMINE SALICYLATE; UNCLASSIFIED DRUG; ZINC OXIDE;

CANCER DIAGNOSIS; CANCER RISK; DIET SUPPLEMENTATION; EPIDEMIOLOGICAL DATA; HEALTH CARE ORGANIZATION; HUMAN; INCIDENCE; INTERNATIONAL COOPERATION; LIGHT; MEDICAL SOCIETY; PHOTOALLERGY; PHOTOTOXICITY; RADIATION EXPOSURE; REVIEW; RISK ASSESSMENT; SKIN CANCER; SUN EXPOSURE; SUNLIGHT PROTECTION; SYSTEMIC THERAPY; ULTRAVIOLET RADIATION; UNITED STATES;

EID: 4043153273     PISSN: 10506934     EISSN: None     Source Type: Journal    
DOI: 10.1615/JLongTermEffMedImplants.v14.i4.40     Document Type: Review

References (74)

1. Centers for Disease Control and Prevention. Notice to readers national melanoma/skin cancer detection and prevention month - May 1998. MMWR 1998; 47(16):343.
2. Public Health Service. Healthy people 2000: national health promotion and disease prevention objectives-full report, with commentary. Washington, DC: US Department of Health and Human Services, Public Health Service, 1990; DHHS publication no. (PHS)91-50212.
3. Hurst EA, Harbour JW, Cornelius LA. Ocular melanoma: a review and the relationship to cutaneous melanoma. Arch Dermatol 2003; 139:1067-1073.
4. Glanz K, Saraiya M, Wechsler H. Guidelines for school programs to prevent skin cancer. MMWR 2202; 51:1-24.
5. Molina MJ, Rowland FS. Stratospheric sink for chlorofluoromethanes: Chlorine atom-catalysed destruction of ozone. Nature 1974; 249:810-812.
6. Diffey BL. Analysis of the risk of skin cancer from sunlight and solaria in subjects living in northern Europe. Photo-Dermatology 1987; 4:118-126.
7. Causes and effects of stratospheric ozone depletion: An update. Washington, DC, National Academy Press, 1982.
8. Streilein JW. UVB susceptibility: possible relationship to photoaging and photocarcinogenesis. In: Gilchrest BA, editor. Photodamage. Blackwell Science, 1995.
9. Henriksen T, Dahlback A, Larsen SH, Moan J. Ultraviolet-radiation and skin cancer: effect of an ozone layer depletion. Photochem Photobiol 1990; 51:579-582.
10. De Grujjl FR, Lonsgtreth J, Norval M, Cullen AP, Slaper H, Kripke ML, Takizawa Y, van der Leun JC. Health effects from stratospheric ozone depletion and interactions with climate change. Photochem Photobiol Sci 2003; 2(1):16-28.
11. McKenzie R, Connor B, Bodeker G. Increased summertime UV radiation in New Zealand in response to ozone loss. Science 1999; 285:1709-1711.
12. Diffey BL, Larko O. Clinical climatology. Photo-Dermatology 1984; 1:30-37.
13. Rigel DS, Rigel EG, Rigel AC. Effects of altitude and latitude on ambient UVB radiation. J Am Acad Dermatol 1999; 40:114-116.
14. Sliney DH, Wood Jr RL, Moscato PM, et al. Ultraviolet exposure in the outdoor environment: measurements of ambient ultraviolet exposure levels at large zenith angles. In: Grandolfo M, Rindi A, Sliney DH, editors. Light, Lasers, and Synchrotron Radiation: A Health Risk Assessment. Plenum Press, 1990.
15. Edlich RF, Boyd LM. Photosensitivity and other adverse reactions to sunlight. In: Edlich RF, editor. Advances In Medicine, 1st ed. Arlington, VA: ABI Professional Publications, 2000.
16. Hanson KM, Simon JD. Epidermal trans-urocanic acid and the UV-A-induced photoaging of the skin. Proc Natl Acad Sci USA 1998; 95:10576-10578.
17. Gange RW, Blackett AD, Matzinger EA, Sutherland BM, Kochevar IE. Comparative protection efficiency of UVA- and UVB-induced tans against erythema and formation of endonuclease-sensitive sites in DNA by UVB in human skin. J Invest Dermatol 1985; 85:362-364
18. Miller SA, Hamilton SL, Wester UG, Cyr WH. An analysis of UVA emissions from sunlamps and the potential importance for melanoma. Photochem Photobiol 1998; 68:63-70.
19. McKinlay AF, Diffey BL. A reference action spectrum for ultraviolet induced erythema in human skin. CIE J 1987; 6:17-22.
20. Black HS, deGruijl FR, Forbes PD, Cleaver JE. Photocarcinogenesis: an overview. Photochem Photobiol 1997; 40:29-47.
21. Rapaport MJ, Rapaport V. Preventive and therapeutic approaches to short-and long-term sun damaged skin. Clin Dermatol 1998; 16:429-439.
22. Duteil L, Queille-Roussel C, Lorenz B, Thieroff-Ekerdt R, Ortonne J-P. A randomized, controlled study of the safety and efficacy of topical corticosteroid treatments of sunburn in healthy volunteers. Clin Exper Dermatol 2002; 27:1314-1318.
23. Liu DR, Kirchner HL, Petrack EM. Does using heat with eutectic mixture of local anesthetic cream shorten analgesic onset time?: a randomized, placebo-trial. Ann Emerg Med 2003; 42(1):27-33
24. Freeman SE, Hacham H, Gange RW, Maytum D, Sutherland JC. Wavelength dependence of pyrimidine dimmer formation in DNA of human skin irradiated in situ with untraviolet light. Proc Nad Acad Sci USA 1989; 86:5605-5609.
25. Brash DE, Ziegler A, Jonason AS, et al: Sunlight and sunburn in human skin cancer p53, apoptosis, and tumor promostion. J Investig Dermatol Symp Proc 1996:1:136-142.
26. Diffey BL, Elwood JM. Tables of ambient solar ultraviolet radiation for use in epidemiological studies of malignant melanoma and other disease. In: Gallager RP, Elwood JM, editors. Epidemiological Aspects of Cutaneous Malignant Melanoma. Boston, Kluwer Academic Publisher, 1994.
27. Runger TM. Role of UVA in the pathogenesis of melanoma and non-melanoma skin cancer - a short review. Photodermatol Photoimmunol Photomed 1999; 15:212-216.
28. Holly EA, Aston DA, Cress RD, Ahn DK, Kristiansen JJ. Cutaneous melanoma in women. Exposure to sunlight, ability to tan, and other risk factors related to ultraviolet light. Am J Epidemiol 1995; 141: 923-933.
29. Centers for Disease Control and Prevention. Counseling to prevent skin cancer recommendations and rationale of the U.S. preventive services task force. MMWR 2003; 52(RR-15)1-16.
30. LeVee GJ, Oberhelman L, Anderson T, Koren H, Cooper KD. UVA II exposure of human skin results in decreased immunization capacity, increased induction of tolerance and a unique pattern of epidermal antigen-presenting cell alteration. Photochem Photobiol 1997; 65:622-629.
31. Krutmann J. Ultraviolet A radiation-induced biological effects in human skin: relevance for photoaging and photodermatosis. J Dermatol Sci 2000; 23 Suppl 1:S22-26.
32. Gasparro FP. Psoralen photobiology: recent advances. Photochem Photobiol 1996; 63:553-557.
33. Fourtanier A, Gueniche A, Compan D, Walker SL, Young AR. Improved protection against solar-simulated radiations-induced immunosuppression by a sunscreen with enhanced ultraviolet A protection. J Invest Dermatol 2000; 114:620-627.
34. Zouboulis CC. Retinoids-which dermatological indications will benefit in the near future? Skin Pharmacol Appl Skin Physiol 2001; 14:303-315.
35. Jones CA, Humberman E, Cunningham ML, Peak MJ. Mutagenesis and cytotoxicity in human epithelial cells by far- and near-ultraviolet radiations: action spectra. Radiat Res 1987; 110:244-254.
36. Food and Drug Administration. Sunscreen drug products for over-the-counter human use; final monograph. HHS. Final rule. Fed Regis 1999 May 21; 64(98):27666-27693.
37. Lim HW, Naylor M, Hönigsmann H, Gilchrest BA, Cooper K, Morison W, DeLeo VA, Scherschun L. American Academy of Dermatology Consensus Conference on UVA Protection of Sunscreens: Summary and Recommendations. J Am Acad Dermatol 2001; 44:505-508.
38. Klein K. Formulating sunscreen products. In: Lowe NJ, Shaath NA, Pathak MA, editors. Sunscreens: Development, Evaluation, and Regulatory Aspects. New York: Marcel Dekker, 1990.
39. Schauder S, Ippen H. Contact and photocontact sensitivity to sunscreens. Review of a 15-year experience and of the literature. Contact Dermatitis: University of Gottingen, Germany 1997; 221-232.
40. Warner WG, Yin JJ, Wei RR. Oxidative damage to nucleic acids photosensitized by titanium dioxide. Free Rad Biol Med 1997; 851-858.
41. Agrapidis-Paolympis LE, Nash RA, Shaath NA. The effect of solvents on the ultraviolet absorbance of sunscreens. J Soc Cosmet Chem 1987.
42. Pogoda JM, Preston-Martin S. Solar radiation, lip protection, and lip cancer risk in Los Angeles County women (California, United States). Cancer Causes Control 1996; 7:458-463.
43. Tarras-Wahlberg N, Stenhagen G, Larko O, Rosen A, Wennberg AM, Wennerstrom O. Changes in ultraviolet absorption of sunscreens after ultraviolet irradiation. J Invest Dermatol 1999; 113:547-553.
44. Deflandre A, Lang G. Photostability assessment of sunscreens: benzylidene camphor and dibenzoylmethane derivatives. Int J Cosmetic Sci 1988: 53-62.
45. Schnuch A, Geier J, Uter W, Frosch PJ. Patch testing with preservatives, antimicrobials and industrial biocides. Results from a multicentre study. Br J Dermatol 1998 Mar; 138(3):467-476.
46. Mowad CM. Allergic contact dermatitis caused by parabens: 2 case reports and a review. Am J Contact Dermat 2000; 11(1):53-56.
47. Hectorne KJ, Fransway AF. Diazolidinyl urea: incidence of sensitivity, patterns of cross-reactivity and clinical relevance. Contact Dermatit 1994; 30(1): 16-19.
48. Williams 3rd RO, Mahaguana V, Sriwongjanya M. Determination of diazolidinyl urea in a topical cream by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 1997; 29(2): 303-306.
49. Darvay A, White IR, Rycroft RJG, Jones AB, Hawk JLM, McFadden JP. Photoallergic contact dermatitis is uncommon. Br J Dermatol 2001; 145:597-601
50. Shindo Y, Witt E, Han D, Epstein W, Packer L. Enzymic and non-enzymic antioxidants in epidermis and dermis of human skin. J Invest Dermatol 1994; 102:122-124.
51. Darr D, Combs S, Dunston S, Manning T, Pinnell S. Topical vitamin C protects porcine skin from ultraviolet radiation-induced damage. Br J Dermatol 1992; 127:247-253.
52. Nakamura T, Pinnell SR, Darr D, Kurimoto I, Itami S, Yoshikawa K, Streilein JW. Vitamin C abrogates the deleterious effects of UVB radiation on cutaneous immunity by a mechanism that does not depend on TNF-alpha. J Invest Dermatol 1997; 109: 20-24.
53. Khettab N, Amory MC, Briand G, Bousquet B, Combre A, Forlot P, Barey M. Photoprotective effect of vitamins A and E on polyamine and oxygenated free radical metabolism in hairless mouse epidermis. Biochimie 1988; 70:1709-1713.
54. Lopez-Torres M, Thiele JJ, Shindo Y, Han D, Packer L. Topical application A alpha-tocopherol modulates the antioxidant network and diminishes ultraviolet-induced oxidative damage in murine skin. Br J Dermatol 1998; 138:207-215.
55. Podda M, Traber MG, Packer L. Alpha-lipoate: antioxidant properties and effects on skin. In: Fuchs J, Packer L, Zimmer G, editors. Lipoic Acid in Health and Disease. New York. Marcel Dekker 1997.
56. Leccia MT, Richard MJ, Beani JC, Faure H, Monjo AM, Cadet J, Amblard P, Favier A. Protective effect of selenium and zinc on UV-A damage in human skin fibroblasts. Photochem Photobiol 1993; 58: 548-553.
57. Leccia MT, Richard MJ, Favier A, Beani JC. Zinc protects against ultraviolet AI-induced DNA damage and apoptosis in cultured human fibroblasts. Biol Trace Elem Res 1999; 69:177-190.
58. Reeve VE, Nishimura N, Bosnic M, et al. Dietary zinc- photoimmunosuppression and metallothionein (MT). In: Klaassen C, editor. Metallothionein IV. Basel, Birkhauser Verlag 1999.
59. Record IR, Jannes M, Dreosti IE. Protection by zinc against UVA- and UVB-induced cellular and genomic damage in vivo and in vitro. Biol Trace Elem Res 1996; 53:19-25.
60. Gonzalez S, Pathak MA, Cuevas J, Villarrubia VG, Fitzpatrick TB. Topical or oral administration with an extract of polypodium leucotomos prevents acute sunburn and psoralen-induced phototoxic reactions as well as depletion of Langerhans cells in human skin. Photodermatol Photoimmunol Photomed 1997; 13:50-60.
61. Eberlein-Konig B, Placzek M, Przybilla B. Protective effect against sunburn of combined systemic ascorbic acid (vitamin C) and D-alpha-tocopherol (vitamin E). J Am Acad Dermatol 1998; 1:45-48.
62. Fuchs J, Kern H. Modulation of UV-light-induced skin inflammation by D-alpha-tocopherol and L-ascorbic acid: a clinical study using solar simulated radiation. Free Radical Biol Med 1998; 25: 1006-1012.
63. Funk JO. Contact sensitization and photocontact sensitization of non-screening agents. In: Lowe NJ, Shaath N, editors. Sunscreens development, evaluation and regulatory aspects: 2 ed. New York: Marcel Dekker, 1997.
64. Murphy GM. The cutaneous porphyrias: a review. The British Photodermatology Group. Br J Dermatol 1999; 140(4):573-581.
65. Dawe SA, Peters TJ, du Vivivier, Creamer JD. Congenital erytharopoietic porphyria: dilemmas in present day management. Clin Exper Dermatol 2002; 27(8):680-683.
66. Cleaver JE, Thompson LH, Richardson AS, States JC. A summary of mutations in the UV-sensitive disorders: xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy. Hum Mutat 1999; 14:9-22.
67. Hasan T, Nyberg F, Stephansson E, Puska P, Hakkinen M, Sarna S, Ros AM, Ranki A. Photosensitivity in lupus erthematosus, UV protoprovocation results compared with history of photosensitivity and clinical findings. Br J Dermatol 1997; 136(5):699-705.
68. Calzavara Pinton PG, Venturini M, Capezzera R, Zane C, Facchetti F. Photosensitive erythema multiforme and erythema multiforme-like polymorphous light eruption. Photodermatol Photoimmunol Photomed 2003; 19:157-159.
69. Czeisler CA, Johnson MP, Duffy JF, Brown EN, Rhonda JM, Kronauer RE. Exposure to bright light and darkness to treat physiologic maladaptation to night work. N Engl J Med 1990; 322:1253-1259.
70. Lieberman HR, Garfield G, Waldhauser F, Lynch HJ, Wurtman RJ. Possible behavioral consequences of light-induced changes in melatonin availability. Ann NY Acad Sci 1985; 453:242-252.
71. Lucey JF. Neonatal jaundice in phototherapy. Pediatr Clin North Am 1972; 19(4):827-839.
72. Emmons KM, Colditz GA. Preventing excess sun exposure: it is time for a national policy. J Natl Cancer Inst 1999; 91(15):1269-1270.
73. Wright NW, Wright ST, Wagner RF. Mechanisms of sunscreen failure. J Am Acad Dermatol 2001; 44: 781-784.
74. Taylor S, Diffey B. Simple dosage guide for sunscreen will help users. BMJ 2002; 324(7352):1526.